Wedbush initiated coverage of Shattuck Labs (STTK) with an Outperform rating and $4 price target
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STTK:
- Shattuck Labs Closes $103M Private Placement Deal
- Cautious Hold on Shattuck Labs Amid Early-Stage Developments and Strategic Positioning
- Shattuck Labs Reports Q2 2025 Financial Results
- Shattuck Labs says IND for SL-325 for treatment of IBD in effect
- Promising Financial Position and SL-325 Potential Drive Buy Rating for Shattuck Labs